Click for best price
Ocular Drug Delivery Market Size, Share 2022
Market Analysis and Insights: Global Ocular Drug Delivery Market
The global Ocular Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ocular Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ocular Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ocular Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ocular Drug Delivery market.
Global Ocular Drug Delivery Scope and Market Size
Ocular Drug Delivery market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
By Company
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Ocular Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Ocular Drug Delivery, with price, sales, revenue, and global market share of Ocular Drug Delivery from 2019 to 2022.
Chapter 3, the Ocular Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ocular Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Ocular Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ocular Drug Delivery.
Chapter 13, 14, and 15, to describe Ocular Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Ocular Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Ocular Drug Delivery Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Ocular Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Ocular Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ocular Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ocular Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Ocular Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Ocular Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ocular Drug Delivery Sales by Region
2.4.1 Global Ocular Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Ocular Drug Delivery by Region (2023-2028)
2.5 Global Ocular Drug Delivery Revenue by Region
2.5.1 Global Ocular Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Ocular Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ocular Drug Delivery Sales by Manufacturers
3.1.1 Global Top Ocular Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ocular Drug Delivery in 2021
3.2 Global Ocular Drug Delivery Revenue by Manufacturers
3.2.1 Global Ocular Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Ocular Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2021
3.3 Global Ocular Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ocular Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ocular Drug Delivery Sales by Type
4.1.1 Global Ocular Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Ocular Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Ocular Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Ocular Drug Delivery Revenue by Type
4.2.1 Global Ocular Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Ocular Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Ocular Drug Delivery Price by Type
4.3.1 Global Ocular Drug Delivery Price by Type (2017-2022)
4.3.2 Global Ocular Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ocular Drug Delivery Sales by Application
5.1.1 Global Ocular Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Ocular Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Ocular Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Ocular Drug Delivery Revenue by Application
5.2.1 Global Ocular Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Ocular Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Ocular Drug Delivery Price by Application
5.3.1 Global Ocular Drug Delivery Price by Application (2017-2022)
5.3.2 Global Ocular Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ocular Drug Delivery Market Size by Type
6.1.1 North America Ocular Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Ocular Drug Delivery Revenue by Type (2017-2028)
6.2 North America Ocular Drug Delivery Market Size by Application
6.2.1 North America Ocular Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Ocular Drug Delivery Revenue by Application (2017-2028)
6.3 North America Ocular Drug Delivery Market Size by Country
6.3.1 North America Ocular Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Ocular Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Ocular Drug Delivery Market Size by Type
7.1.1 Europe Ocular Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Ocular Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Ocular Drug Delivery Market Size by Application
7.2.1 Europe Ocular Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Ocular Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Ocular Drug Delivery Market Size by Country
7.3.1 Europe Ocular Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Ocular Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ocular Drug Delivery Market Size by Type
8.1.1 Asia Pacific Ocular Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Ocular Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Ocular Drug Delivery Market Size by Application
8.2.1 Asia Pacific Ocular Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Ocular Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Ocular Drug Delivery Market Size by Region
8.3.1 Asia Pacific Ocular Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Ocular Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Ocular Drug Delivery Market Size by Type
9.1.1 Latin America Ocular Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Ocular Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Ocular Drug Delivery Market Size by Application
9.2.1 Latin America Ocular Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Ocular Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Ocular Drug Delivery Market Size by Country
9.3.1 Latin America Ocular Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Ocular Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ocular Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Ocular Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ocular Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Ocular Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Ocular Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ocular Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Ocular Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Ocular Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ocular Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Corporation Information
11.1.2 OCULAR THERAPEUTIX, INC Overview
11.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 OCULAR THERAPEUTIX, INC Recent Developments
11.2 Alimera Sciences
11.2.1 Alimera Sciences Corporation Information
11.2.2 Alimera Sciences Overview
11.2.3 Alimera Sciences Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Alimera Sciences Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alimera Sciences Recent Developments
11.3 Allergan, Plc
11.3.1 Allergan, Plc Corporation Information
11.3.2 Allergan, Plc Overview
11.3.3 Allergan, Plc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Allergan, Plc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Allergan, Plc Recent Developments
11.4 EyeGate Pharma
11.4.1 EyeGate Pharma Corporation Information
11.4.2 EyeGate Pharma Overview
11.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 EyeGate Pharma Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 EyeGate Pharma Recent Developments
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
11.5.2 Valeant Pharmaceuticals International, Inc Overview
11.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valeant Pharmaceuticals International, Inc Recent Developments
11.6 Envisia Therapeutics
11.6.1 Envisia Therapeutics Corporation Information
11.6.2 Envisia Therapeutics Overview
11.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Envisia Therapeutics Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Envisia Therapeutics Recent Developments
11.7 Clearside Biomedical
11.7.1 Clearside Biomedical Corporation Information
11.7.2 Clearside Biomedical Overview
11.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Clearside Biomedical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Clearside Biomedical Recent Developments
11.8 Graybug Vision Inc
11.8.1 Graybug Vision Inc Corporation Information
11.8.2 Graybug Vision Inc Overview
11.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Graybug Vision Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Graybug Vision Inc Recent Developments
11.9 Taiwan Liposome Company
11.9.1 Taiwan Liposome Company Corporation Information
11.9.2 Taiwan Liposome Company Overview
11.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Taiwan Liposome Company Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taiwan Liposome Company Recent Developments
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Corporation Information
11.10.2 Santen Pharmaceutical Overview
11.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Santen Pharmaceutical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Santen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ocular Drug Delivery Industry Chain Analysis
12.2 Ocular Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ocular Drug Delivery Production Mode & Process
12.4 Ocular Drug Delivery Sales and Marketing
12.4.1 Ocular Drug Delivery Sales Channels
12.4.2 Ocular Drug Delivery Distributors
12.5 Ocular Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ocular Drug Delivery Industry Trends
13.2 Ocular Drug Delivery Market Drivers
13.3 Ocular Drug Delivery Market Challenges
13.4 Ocular Drug Delivery Market Restraints
14 Key Findings in The Global Ocular Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Ocular Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ocular Insert
Table 3. Major Manufacturers of Iontophoresis
Table 4. Major Manufacturers of Intraocular Implants
Table 5. Major Manufacturers of In Situ Gel & Punctal Plugs
Table 6. Major Manufacturers of Others
Table 7. Global Ocular Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Ocular Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Ocular Drug Delivery Sales by Region (2017-2022) & (K Doses)
Table 10. Global Ocular Drug Delivery Sales Market Share by Region (2017-2022)
Table 11. Global Ocular Drug Delivery Sales by Region (2023-2028) & (K Doses)
Table 12. Global Ocular Drug Delivery Sales Market Share by Region (2023-2028)
Table 13. Global Ocular Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Ocular Drug Delivery Revenue Market Share by Region (2017-2022)
Table 15. Global Ocular Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Ocular Drug Delivery Revenue Market Share by Region (2023-2028)
Table 17. Global Ocular Drug Delivery Sales by Manufacturers (2017-2022) & (K Doses)
Table 18. Global Ocular Drug Delivery Sales Share by Manufacturers (2017-2022)
Table 19. Global Ocular Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Ocular Drug Delivery Revenue Share by Manufacturers (2017-2022)
Table 21. Ocular Drug Delivery Price by Manufacturers (2017-2022) &(USD/Dose)
Table 22. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2021)
Table 24. Ocular Drug Delivery Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Ocular Drug Delivery Product Offered
Table 26. Date of Manufacturers Enter into Ocular Drug Delivery Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
Table 29. Global Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
Table 30. Global Ocular Drug Delivery Sales Share by Type (2017-2022)
Table 31. Global Ocular Drug Delivery Sales Share by Type (2023-2028)
Table 32. Global Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Ocular Drug Delivery Revenue Share by Type (2017-2022)
Table 35. Global Ocular Drug Delivery Revenue Share by Type (2023-2028)
Table 36. Ocular Drug Delivery Price by Type (2017-2022) & (USD/Dose)
Table 37. Global Ocular Drug Delivery Price Forecast by Type (2023-2028) & (USD/Dose)
Table 38. Global Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
Table 39. Global Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
Table 40. Global Ocular Drug Delivery Sales Share by Application (2017-2022)
Table 41. Global Ocular Drug Delivery Sales Share by Application (2023-2028)
Table 42. Global Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Ocular Drug Delivery Revenue Share by Application (2017-2022)
Table 45. Global Ocular Drug Delivery Revenue Share by Application (2023-2028)
Table 46. Ocular Drug Delivery Price by Application (2017-2022) & (USD/Dose)
Table 47. Global Ocular Drug Delivery Price Forecast by Application (2023-2028) & (USD/Dose)
Table 48. North America Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
Table 49. North America Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
Table 50. North America Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
Table 53. North America Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
Table 54. North America Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
Table 57. North America Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
Table 58. North America Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
Table 61. Europe Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
Table 62. Europe Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
Table 65. Europe Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
Table 66. Europe Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
Table 69. Europe Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
Table 70. Europe Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
Table 73. Asia Pacific Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
Table 74. Asia Pacific Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
Table 77. Asia Pacific Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
Table 78. Asia Pacific Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Ocular Drug Delivery Sales by Region (2017-2022) & (K Doses)
Table 81. Asia Pacific Ocular Drug Delivery Sales by Region (2023-2028) & (K Doses)
Table 82. Asia Pacific Ocular Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Ocular Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
Table 85. Latin America Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
Table 86. Latin America Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
Table 89. Latin America Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
Table 90. Latin America Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
Table 93. Latin America Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
Table 94. Latin America Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Ocular Drug Delivery Sales by Type (2017-2022) & (K Doses)
Table 97. Middle East and Africa Ocular Drug Delivery Sales by Type (2023-2028) & (K Doses)
Table 98. Middle East and Africa Ocular Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Ocular Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Ocular Drug Delivery Sales by Application (2017-2022) & (K Doses)
Table 101. Middle East and Africa Ocular Drug Delivery Sales by Application (2023-2028) & (K Doses)
Table 102. Middle East and Africa Ocular Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Ocular Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Ocular Drug Delivery Sales by Country (2017-2022) & (K Doses)
Table 105. Middle East and Africa Ocular Drug Delivery Sales by Country (2023-2028) & (K Doses)
Table 106. Middle East and Africa Ocular Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Ocular Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 108. OCULAR THERAPEUTIX, INC Corporation Information
Table 109. OCULAR THERAPEUTIX, INC Description and Major Businesses
Table 110. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 111. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. OCULAR THERAPEUTIX, INC Recent Developments
Table 113. Alimera Sciences Corporation Information
Table 114. Alimera Sciences Description and Major Businesses
Table 115. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 116. Alimera Sciences Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Alimera Sciences Recent Developments
Table 118. Allergan, Plc Corporation Information
Table 119. Allergan, Plc Description and Major Businesses
Table 120. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 121. Allergan, Plc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Allergan, Plc Recent Developments
Table 123. EyeGate Pharma Corporation Information
Table 124. EyeGate Pharma Description and Major Businesses
Table 125. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 126. EyeGate Pharma Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. EyeGate Pharma Recent Developments
Table 128. Valeant Pharmaceuticals International, Inc Corporation Information
Table 129. Valeant Pharmaceuticals International, Inc Description and Major Businesses
Table 130. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 131. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Valeant Pharmaceuticals International, Inc Recent Developments
Table 133. Envisia Therapeutics Corporation Information
Table 134. Envisia Therapeutics Description and Major Businesses
Table 135. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 136. Envisia Therapeutics Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Envisia Therapeutics Recent Developments
Table 138. Clearside Biomedical Corporation Information
Table 139. Clearside Biomedical Description and Major Businesses
Table 140. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 141. Clearside Biomedical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Clearside Biomedical Recent Developments
Table 143. Graybug Vision Inc Corporation Information
Table 144. Graybug Vision Inc Description and Major Businesses
Table 145. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 146. Graybug Vision Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Graybug Vision Inc Recent Developments
Table 148. Taiwan Liposome Company Corporation Information
Table 149. Taiwan Liposome Company Description and Major Businesses
Table 150. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 151. Taiwan Liposome Company Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Taiwan Liposome Company Recent Developments
Table 153. Santen Pharmaceutical Corporation Information
Table 154. Santen Pharmaceutical Description and Major Businesses
Table 155. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 156. Santen Pharmaceutical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Santen Pharmaceutical Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Ocular Drug Delivery Distributors List
Table 161. Ocular Drug Delivery Customers List
Table 162. Ocular Drug Delivery Market Trends
Table 163. Ocular Drug Delivery Market Drivers
Table 164. Ocular Drug Delivery Market Challenges
Table 165. Ocular Drug Delivery Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Ocular Drug Delivery Product Picture
Figure 3. Global Ocular Drug Delivery Market Share by Type in 2021 & 2028
Figure 3. Ocular Insert Product Picture
Figure 4. Iontophoresis Product Picture
Figure 5. Intraocular Implants Product Picture
Figure 6. In Situ Gel & Punctal Plugs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Ocular Drug Delivery Market Share by Application in 2021 & 2028
Figure 9. Hospitals
Figure 10. Ambulatory Surgical Centers
Figure 11. Ophthalmic Clinics
Figure 12. Homecare Settings
Figure 13. Ocular Drug Delivery Report Years Considered
Figure 14. Global Ocular Drug Delivery Sales 2017-2028 (K Doses)
Figure 15. Global Ocular Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Ocular Drug Delivery Revenue 2017-2028 (US$ Million)
Figure 17. Global Ocular Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Ocular Drug Delivery Sales Market Share by Region (2017-2022)
Figure 19. Global Ocular Drug Delivery Sales Market Share by Region (2023-2028)
Figure 20. North America Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
Figure 21. North America Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
Figure 23. Europe Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
Figure 25. Asia-Pacific Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
Figure 27. Latin America Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Ocular Drug Delivery Sales YoY (2017-2028) & (K Doses)
Figure 29. Middle East & Africa Ocular Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Ocular Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Ocular Drug Delivery in the World: Market Share by Ocular Drug Delivery Revenue in 2021
Figure 32. Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Ocular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 34. Global Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 35. Global Ocular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 36. Global Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 37. North America Ocular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 38. North America Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 39. North America Ocular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 40. North America Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 41. North America Ocular Drug Delivery Sales Share by Country (2017-2028)
Figure 42. North America Ocular Drug Delivery Revenue Share by Country (2017-2028)
Figure 43. U.S. Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Ocular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 46. Europe Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 47. Europe Ocular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 48. Europe Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 49. Europe Ocular Drug Delivery Sales Share by Country (2017-2028)
Figure 50. Europe Ocular Drug Delivery Revenue Share by Country (2017-2028)
Figure 51. Germany Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 52. France Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Ocular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Ocular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Ocular Drug Delivery Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Ocular Drug Delivery Revenue Share by Region (2017-2028)
Figure 62. China Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 65. India Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Ocular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 73. Latin America Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Ocular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 75. Latin America Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Ocular Drug Delivery Sales Share by Country (2017-2028)
Figure 77. Latin America Ocular Drug Delivery Revenue Share by Country (2017-2028)
Figure 78. Mexico Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Ocular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Ocular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Ocular Drug Delivery Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Ocular Drug Delivery Revenue Share by Country (2017-2028)
Figure 87. Turkey Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Ocular Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 90. Ocular Drug Delivery Value Chain
Figure 91. Ocular Drug Delivery Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
